Filtros : "Hot spots" Limpar

Filtros



Refine with date range


  • Source: Current Topics in Medicinal Chemistry. Unidade: FCFRP

    Subjects: ANTIVIRAIS, TRYPANOSOMA CRUZI, DOENÇAS PARASITÁRIAS

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      FROES, Thamires Quadros et al. DHODH hot spots: an underexplored source to guide drug development efforts. Current Topics in Medicinal Chemistry, v. 21, n. 23, p. 2134-2154, 2021Tradução . . Disponível em: https://doi.org/10.2174/1568026621666210804122320. Acesso em: 29 jan. 2026.
    • APA

      Froes, T. Q., Zapata, L. C. C., Akamine, J. S., Castilho, M. S., & Nonato, M. C. (2021). DHODH hot spots: an underexplored source to guide drug development efforts. Current Topics in Medicinal Chemistry, 21( 23), 2134-2154. doi:10.2174/1568026621666210804122320
    • NLM

      Froes TQ, Zapata LCC, Akamine JS, Castilho MS, Nonato MC. DHODH hot spots: an underexplored source to guide drug development efforts [Internet]. Current Topics in Medicinal Chemistry. 2021 ; 21( 23): 2134-2154.[citado 2026 jan. 29 ] Available from: https://doi.org/10.2174/1568026621666210804122320
    • Vancouver

      Froes TQ, Zapata LCC, Akamine JS, Castilho MS, Nonato MC. DHODH hot spots: an underexplored source to guide drug development efforts [Internet]. Current Topics in Medicinal Chemistry. 2021 ; 21( 23): 2134-2154.[citado 2026 jan. 29 ] Available from: https://doi.org/10.2174/1568026621666210804122320
  • Source: Expert Opinion on Drug Discovery. Unidade: IFSC

    Subjects: PROTEÍNAS, CRISTALOGRAFIA DE RAIOS X, NEOPLASIAS

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      FERREIRA, Leonardo Luiz Gomes e OLIVA, Glaucius e ANDRICOPULO, Adriano Defini. Protein-protein interaction inhibitors: advances in anticancer drug design. Expert Opinion on Drug Discovery, v. 11, n. 10, p. 957-968, 2016Tradução . . Disponível em: https://doi.org/10.1080/17460441.2016.1223038. Acesso em: 29 jan. 2026.
    • APA

      Ferreira, L. L. G., Oliva, G., & Andricopulo, A. D. (2016). Protein-protein interaction inhibitors: advances in anticancer drug design. Expert Opinion on Drug Discovery, 11( 10), 957-968. doi:10.1080/17460441.2016.1223038
    • NLM

      Ferreira LLG, Oliva G, Andricopulo AD. Protein-protein interaction inhibitors: advances in anticancer drug design [Internet]. Expert Opinion on Drug Discovery. 2016 ; 11( 10): 957-968.[citado 2026 jan. 29 ] Available from: https://doi.org/10.1080/17460441.2016.1223038
    • Vancouver

      Ferreira LLG, Oliva G, Andricopulo AD. Protein-protein interaction inhibitors: advances in anticancer drug design [Internet]. Expert Opinion on Drug Discovery. 2016 ; 11( 10): 957-968.[citado 2026 jan. 29 ] Available from: https://doi.org/10.1080/17460441.2016.1223038

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2026